(Q47789168)

5 February 2018

title

Assessing the applicability of trial evidence to a target sample in the presence of heterogeneity of treatment effect (English)

1 reference

5 February 2018

author name string

Carlos O Weiss

series ordinal

1

1 reference

5 February 2018

Jodi B Segal

series ordinal

2

1 reference

5 February 2018

Ravi Varadhan

series ordinal

3

1 reference

5 February 2018

publication date

1 May 2012

1 reference

5 February 2018

Pharmacoepidemiology and Drug Safety

published in

1 reference

5 February 2018

volume

21 Suppl 2

1 reference

5 February 2018

page(s)

121-129

1 reference

5 February 2018

The double-blind, randomized, placebo-controlled trial: gold standard or golden calf?

cites work

1 reference

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

21 January 2018

1 reference

Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

21 January 2018

1 reference

The calibration of treatment effects from clinical trials to target populations

21 January 2018

1 reference

Empirical evaluation of the generalizability of the sample from the multimodal treatment study for ADHD.

21 January 2018

1 reference

Generalizing from clinical trial data: a case study. The risk of suicidality among pediatric antidepressant users

21 January 2018

1 reference

Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial

21 January 2018

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications

21 January 2018

1 reference

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

Index to predict 5-year mortality of community-dwelling adults aged 65 and older using data from the National Health Interview Survey

21 January 2018

1 reference

Development and validation of a prognostic index for 4-year mortality in older adults.

21 January 2018

1 reference

A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors

21 January 2018

1 reference

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure.

21 January 2018

1 reference

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

Detecting Systematic Errors in Multi-Clinic Observational Data

21 January 2018

1 reference

Biplots in biomedical research.

21 January 2018

1 reference

Multiple imputation using chained equations: Issues and guidance for practice

21 January 2018

1 reference

The population risk as an explanatory variable in research synthesis of clinical trials.

21 January 2018

1 reference

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

21 January 2018

1 reference

A new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases.

21 January 2018

1 reference

The confidence profile method: a Bayesian method for assessing health technologies.

21 January 2018

1 reference

Communicating the uncertainty of harms and benefits of medical interventions

21 January 2018

1 reference

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study

21 January 2018

1 reference

A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group

21 January 2018

1 reference

Consequences of event rate heterogeneity across non-randomized study sub-groups.

21 January 2018

1 reference

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm

21 January 2018

1 reference

Variation in baseline risk as an explanation of heterogeneity in meta-analysis

21 January 2018

1 reference

Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches.

21 January 2018

1 reference

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

21 January 2018

1 reference

Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.3242

1 reference

5 February 2018

1 reference

5 February 2018